qEV Publication Watch: Q4 2023

Extracellular Vesicles
About /

A snapshot of publications built on qEV isolation technology, from the final quarter of 2023.

1. Crucial insights into microglial-derived EVs’ involvement in neuroinflammation

Santiago, J. V. et al. Identification of state-specific proteomic and transcriptomic signatures of microglia-derived extracellular vesicles. Molecular & Cellular Proteomics 22, 100678–100678 (2023). doi:https://pubmed.ncbi.nlm.nih.gov/37952696/

2. Plasma EVs show promise as a biomarker for osteoarthritis stage progression

Matejová, J. et al. Plasma-derived extracellular vesicle surface markers CD45, CD326 and CD56 correlate with the stage of osteoarthritis: A primary study of a novel and promising diagnostic tool of the disease. Scientific Reports 13, (2023). doi:https://doi.org/10.1038/s41598-023-47074-z

3. SEC by qEV is a favourable method for maintaining high purity after EV isolation

Chee, T., et al. Optimal isolation of extracellular vesicles from pleural fluid and profiling of their microRNA cargo. Journal of Extracellular Biology, (2023). doi:https://doi.org/10.1002/jex2.119

4. Muscle cell-derived exosomes are involved in the synchronisation of muscle and bone aging

Yin, P. et al. Deciphering immune landscape remodeling unravels the underlying mechanism for synchronized muscle and bone aging. Advanced Science (2023). doi:https://doi.org/10.1002/advs.202304084.

5. Cancer vaccines a real possibility thanks to EV tagging technology

Bhatta, R. et al. Metabolic tagging of extracellular vesicles and development of enhanced extracellular vesicle based cancer vaccines. Nature Communications 14, (2023). doi:https://doi.org/10.1038/s41467-023-43914-8

6. EV proteins may hold prognostic and diagnostic capabilities for plasma cell disorder patients (preprint)

Patrick M. Vanderboom, Yogesh Chawla, Surendra Dasari et al. Evaluating differences in the proteome within extracellular vesicles between pre- malignant and malignant plasma cell disorders, 30 November 2023, PREPRINT (Version 1) available at Research Square https://doi.org/10.21203/rs.3.rs-3673796/v1

7. Characterisation of activated macrophage derived EVs involved in periodontal disease

Lim, Y., Kim, H., Han, D. & Choi, B. Proteome and immune responses of extracellular vesicles derived from macrophages infected with the periodontal pathogen Tannerella forsythia. Journal of Extracellular Vesicles 12, (2023). doi:https://doi.org/10.1002/jev2.12381

8. Therapeutic EVs regulate pancreatic cancer genes by a qEV-mediated methodology

Chiang, C.-L. et al. Dual targeted extracellular vesicles regulate oncogenic genes in advanced pancreatic cancer. Nature Communications 14, 6692 (2023). doi:https://doi.org/10.1038/s41467-023-42402-3

9. Autism Spectrum Disorder modulated by changes in the periphery, mediated by EVs

Chen, L. et al. Blood exosome sensing via neuronal insulin-like growth factor-1 regulates autism-related phenotypes. Pharmacological Research 197, 106965–106965 (2023). doi:https://doi.org/10.1016/j.phrs.2023.106965

10. Antiviral packaged EV therapy shows promise as a COVID-19 treatment

Jayasinghe, M. K. et al. Red blood cell-derived extracellular vesicles display endogenous antiviral effects and enhance the efficacy of antiviral oligonucleotide therapy. ACS Nano 17, 21639–21661 (2023). doi:https://doi.org/10.1021/acsnano.3c06803

Ready to streamline your EV isolation? Here's how.


Related Articles

View All

Subscribe to our newsletter!

Get the latest qEV and TRPS news straight to your inbox.

Check out "qEV Publication Watch: Q4 2023" on Izon

No items found.
No items found.
No items found.
No items found.
URL Copied!